‘During today’s Senate Commerce, Science, and Transportation Committee hearing on the future of 5G wireless technology and their impact on the American people and economy, U.S. Senator Richard Blumenthal (D-CT) raised concerns with the lack of any scientific research and data on the technology’s potential health risks.
Blumenthal blasted the Federal Communications Commission (FCC) and the Food and Drug Administration (FDA)—government agencies jointly-responsible for ensuring that cellphone technologies are safe to use—for failing to conduct any research into the safety of 5G technology, and instead, engaging in bureaucratic finger-pointing and deferring to industry.
In December 2018, Blumenthal and U.S. Representative Anna G. Eshoo (CA-18) sent a letter to FCC Commissioner Brendan Carr seeking answers regarding potential health risks posed by new 5G wireless technology. At today’s hearing, Blumenthal criticized Carr for failing to provide answers, and instead, just echoing, “the general statements of the FDA, which shares regulatory responsibility for cell phones with the FCC.” Blumenthal also decried the FDA’s statements as “pretty unsatisfactory.” A PDF of Carr’s complete response is available here.
During an exchange with wireless industry representatives, Blumenthal asked them whether they have supported research on the safety of 5G technology and potential links between radiofrequency and cancer, and the industry representatives conceded they have not.
Blumenthal stated:
“If you go to the FDA website, there basically is a cursory and superficial citation to existing scientific data saying ‘The FDA has urged the cell phone industry to take a number of steps, including support additional research on possible biological effects of radio frequency fields for the type of signals emitted by cell phones.’ I believe that Americans deserve to know what the health effects are, not to pre-judge what scientific studies may show, and they also deserve a commitment to do the research on outstanding questions.”
“So my question for you: How much money has the industry committed to supporting additional independent research—I stress independent—research? Is that independent research ongoing? Has any been completed? Where can consumers look for it? And we’re talking about research on the biological effects of this new technology.”
